These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3500674)

  • 1. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations.
    Falk CT; Rubinstein P
    Ann Hum Genet; 1987 Jul; 51(3):227-33. PubMed ID: 3500674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
    Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
    J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes predisposing to IDDM in multiplex families.
    Field LL
    Genet Epidemiol; 1989; 6(1):101-6. PubMed ID: 2499498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of a multiplex IDDM sample: unexplained differences with other samples.
    Falk CT
    Genet Epidemiol; 1989; 6(1):95-100. PubMed ID: 2499506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
    Robinson DM; Holbeck S; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors in insulin-dependent diabetes].
    Deschamps I; Lestradet H; Marcelli-Barge A; Poirier JC; Cohen D; Hors J
    Pathol Biol (Paris); 1986 Jun; 34(6):767-72. PubMed ID: 3531993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
    Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
    Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and insulin gene associations with IDDM.
    Thomson G; Robinson WP; Kuhner MK; Joe S; Klitz W
    Genet Epidemiol; 1989; 6(1):155-60. PubMed ID: 2567257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
    Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
    Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
    Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population.
    Huang HS; Peng JT; She JY; Zhang LP; Chao CC; Liu KH; She JX
    Hum Immunol; 1995 Dec; 44(4):210-9. PubMed ID: 8770634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA DR4-DQw3.1 and 3.2 haplotypes among insulin-dependent diabetics and their unaffected sibs in the GAW5 data.
    Gogolin KJ; Spielman RS
    Genet Epidemiol; 1989; 6(1):113-6. PubMed ID: 2567253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential transmission of diabetic alleles within the HLA gene complex.
    Vadheim CM; Rotter JI; Maclaren NK; Riley WJ; Anderson CE
    N Engl J Med; 1986 Nov; 315(21):1314-8. PubMed ID: 3490623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.
    Undlien DE; Friede T; Rammensee HG; Joner G; Dahl-Jørgensen K; Søvik O; Akselsen HE; Knutsen I; Rønningen KS; Thorsby E
    Diabetes; 1997 Jan; 46(1):143-9. PubMed ID: 8971095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
    Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a german population.
    Badenhoop K; Donner H; Pani M; Rau H; Siegmund T; Braun J
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S89-92. PubMed ID: 10522814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DQ beta restriction fragment length polymorphism and its relationship to insulin dependent diabetes mellitus.
    Sachs JA; Cassell PG; Festenstein H; Awad J; Hitman GA
    Dis Markers; 1987 Dec; 5(4):199-206. PubMed ID: 2901934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci.
    Cucca F; Lampis R; Frau F; Macis D; Angius E; Masile P; Chessa M; Frongia P; Silvetti M; Cao A; De Virgiliis S; Congia M
    Hum Immunol; 1995 Aug; 43(4):301-8. PubMed ID: 7499178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.